EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES EGX:PHAR:
EIPICO 9-MONTH CONSOL NET PROFIT ATTRIBUTABLE EGP 1.09 BILLION
EIPICO 9-MONTH CONSOL REVENUE EGP 7.16 BILLION
EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES EGX:PHAR:
EIPICO 9-MONTH CONSOL NET PROFIT ATTRIBUTABLE EGP 1.09 BILLION
EIPICO 9-MONTH CONSOL REVENUE EGP 7.16 BILLION